Secukinumab Provides Sustained Improvements in Signs and Symptoms in Active Psoriatic Arthritis Up-to 3 years: Data from FUTURE1 and FUTURE2 studies
Author Type(s)
Faculty
Document Type
Abstract
Publication Date
5-2018
Journal Title
Australasian Journal of Dermatology
Department
Dermatology
Disciplines
Medicine and Health Sciences
Recommended Citation
Nash, P., Gottlieb, A. B., McInnes, I., Mease, P., Delicha, E., Pellet, P., Kajekar, R., & Pricop, L. (2018). Secukinumab Provides Sustained Improvements in Signs and Symptoms in Active Psoriatic Arthritis Up-to 3 years: Data from FUTURE1 and FUTURE2 studies. Australasian Journal of Dermatology, 59 (Suppl. 1), 88. Retrieved from https://touroscholar.touro.edu/nymc_fac_abstracts/378
COinS
